Roth Capital Cuts Earnings Estimates for Zevra Therapeutics
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Roth Capital reduced their FY2029 earnings per...
Your Source for Insightful Trends and Discussions.
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Roth Capital reduced their FY2029 earnings per...
Sprouts Farmers Market (NASDAQ:SFM – Get Free Report) had its price objective raised by research...
Arch Capital Group Ltd. (NASDAQ:ACGL – Free Report) – Roth Capital cut their Q2 2025...
MGP Ingredients (NASDAQ:MGPI – Get Free Report) had its target price decreased by Roth Mkm...